IKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Inhibikase Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.65−0.00 (-0.30%)
Close on Oct 19, 2026
- Market cap
- $287.17M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
89.1%
124M of 140M shares
Institutional holders
106
19 new, 14 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $3.00M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ortav Yehudai | 8,057,345 | 6.10% | 13G (passive) amendment | Mar 31, 2026 |
| BlackRock, Inc. | 7,768,004 | 5.90% | 13G (passive) | Jun 30, 2026 |
| Soleus Private Equity Fund III, L.P. | 7,228,908 | 9.99% | 13G (passive) | Oct 21, 2024 |
| Fairmount Funds Management LLC | 7,018,575 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Trails Edge Capital Partners, LP | 6,145,198 | 5.10% | 13G (passive) | Dec 23, 2025 |
| SP Soleus Holdings LLC | 5,840,000 | 8.69% | 13G (passive) | Oct 21, 2024 |
| Wilmot B. Harkey | 5,298,624 | 7.54% | 13G (passive) | Dec 31, 2024 |
| Rajeev Shah | 25,000,000 | 15.90% | 13G (passive) | Jul 10, 2026 |
| RA Capital Healthcare Fund, L.P. | 14,653,994 | 9.90% | 13G (passive) amendment | Jul 29, 2026 |
| Robert Egen Atkinson | 14,054,940 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 13,860,028 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Sands Frank M. | 13,018,965 | 9.30% | 13G (passive) amendment | Jun 30, 2026 |
| Joseph Edelman | 12,816,643 | 9.99% | 13G (passive) amendment | Dec 31, 2025 |
| ADAR1 Capital Management GP, LLC | 12,692,387 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Tomas Kiselak | 12,461,101 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 10,950,000 | 14.70% | 13G (passive) amendment | Jun 30, 2025 |
| Perceptive Advisors LLC | 10,320,875 | 6.90% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IKT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Sands Capital Ventures, LLC | 13,018,965 | 9.33% | $26.43M | – | 4.31% |
| Soleus Capital Management, L.P. | 10,875,000 | 7.79% | $22.08M | – | 0.76% |
| Trails Edge Capital Partners, LP | 9,051,318 | 6.49% | $18.37M | +993,973 | 2.92% |
| Fairmount Funds Management LLC | 8,625,000 | 6.18% | $17.51M | – | 1.16% |
| BlackRock, Inc. | 7,768,057 | 5.57% | $15.77M | +1,464,624 | 0.00% |
| Kalehua Capital Management LLC | 7,643,780 | 5.48% | $15.52M | +1,149,282 | 4.95% |
| ADAR1 Capital Management, LLC | 7,387,205 | 5.29% | $15.00M | +780,633 | 0.69% |
| Blackstone Inc. | 5,938,276 | 4.26% | $12.05M | – | 0.04% |
| Siren, L.L.C. | 5,850,000 | 4.19% | $11.88M | – | 0.24% |
| Nantahala Capital Management, LLC | 5,403,726 | 3.87% | $10.97M | +2,701,863 | 0.18% |
| Commodore Capital LP | 5,397,488 | 3.87% | $10.96M | – | 0.65% |
| Vanguard Capital Management LLC | 4,935,354 | 3.54% | $10.02M | +484,689 | 0.00% |
| Millennium Management LLC | 4,028,102 | 2.89% | $8.18M | +1,100,025 | 0.00% |
| Saturn V Capital Management LP | 3,869,056 | 2.77% | $7.85M | +5,611 | 1.13% |
| Spruce Street Capital LP | 3,581,603 | 2.57% | $7.27M | – | 1.43% |
| Squadron Capital Management LLC | 3,000,000 | 2.15% | $6.09M | −500,000 | 1.89% |
| Geode Capital Management, LLC | 2,607,129 | 1.87% | $5.29M | +436,943 | 0.00% |
| State Street Corp | 1,909,101 | 1.37% | $3.88M | +223,285 | 0.00% |
| SummitTX Capital, L.P. | 1,780,262 | 1.28% | $3.61M | +255,726 | 0.09% |
| Integral Health Asset Management, LLC | 1,350,000 | 0.97% | $2.74M | – | 0.11% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 106 | 124M | 89.1% | 19 / 49 | 23 / 14 | 13M | 7M |
| Q1 2026 | 104 | 118M | 84.4% | 39 / 38 | 14 / 8 | 27M | 11M |
| Q4 2025 | 74 | 106M | 76.3% | 21 / 27 | 15 / 1 | 52M | 0M |
| Q3 2025 | 54 | 55M | 39.4% | 8 / 16 | 15 / 2 | 1M | 1M |
| Q2 2025 | 48 | 55M | 39.1% | 24 / 11 | 6 / 23 | 6M | 3M |
| Q1 2025 | 47 | 51M | 36.9% | 19 / 12 | 3 / 3 | 2M | 1M |
| Q4 2024 | 31 | 50M | 35.9% | 23 / 7 | 0 / 3 | 50M | 1M |
| Q3 2024 | 11 | 1M | 0.6% | 1 / 4 | 2 / 2 | 0M | 0M |
| Q2 2024 | 12 | 1M | 0.6% | 4 / 3 | 3 / 4 | 1M | 0M |
| Q1 2024 | 12 | 0M | 0.1% | 3 / 3 | 4 / 2 | 0M | 0M |
| Q4 2023 | 11 | 0M | 0.2% | 2 / 4 | 3 / 4 | 0M | 0M |
| Q3 2023 | 13 | 0M | 0.3% | 1 / 8 | 3 / 2 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of IKT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,764,138 | 2.70% | $7.64M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3,009,439 | 2.16% | $6.11M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,320,308 | 0.95% | $2.88M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 1,107,121 | 0.79% | $2.25M | 0.02% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,055,770 | 0.76% | $2.14M | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 547,192 | 0.39% | $957.59K | 0.01% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 421,326 | 0.30% | $737.32K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 406,711 | 0.29% | $825.62K | 0.05% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 294,004 | 0.21% | $640.93K | 0.01% | Jul 31, 2026 |
| Master Small Cap Index Series | 236,794 | 0.17% | $480.69K | 0.01% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 215,750 | 0.15% | $437.97K | 0.00% | Jun 30, 2026 |
| JPMorgan Small Cap Value Fund | 171,152 | 0.12% | $347.44K | 0.03% | Jun 30, 2026 |
| Fidelity Small Cap Value Index Fund | 169,113 | 0.12% | $343.30K | 0.02% | Jun 30, 2026 |
| Nuveen Small Cap Blend Index Fund | 161,780 | 0.12% | $352.68K | 0.01% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 143,459 | 0.10% | $251.05K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mark T. Iwicki | Chief Executive Officer, Director | – | – | Jan 7, 2026 |
| Milton H. Werner | President and CEO, Director | 5,359,022 | 3.84% | Jan 22, 2025 |
| Christopher Cabell | President & Head of R&D | 676,564 | 0.48% | Feb 24, 2026 |
| David McIntyre | Chief Financial Officer | 10,285 | 0.01% | Jan 7, 2026 |
| Garth Lees-Rolfe | Chief Financial Officer | – | – | Jan 22, 2025 |
| Dennis N. Berman | Director | 21,854 | 0.02% | Jul 31, 2026 |
| Arvind Kush | Director | 145,000 | 0.10% | Jun 30, 2026 |
| Amit Munshi | Director | 403,176 | 0.29% | Jun 30, 2026 |
| Roberto Bellini | Director | 1,460,000 | 1.05% | Jun 30, 2026 |
| Vincent Aurentz | Director | 510,596 | 0.37% | Jun 30, 2026 |
| David Canner | Director | – | – | Jun 30, 2026 |
| Roy Lester Freeman | Director | – | – | Feb 19, 2025 |
| Capital Healthcare Fund LP RA | 10% owner | 6,970,000 | 5.00% | Jul 31, 2026 |
| Ra Capital Management, L.P. | 10% owner | – | – | Jul 31, 2026 |
| Peter Kolchinsky | 10% owner | – | – | Jul 31, 2026 |
| Rajeev M. Shah | 10% owner | – | – | Jul 31, 2026 |
| Sands Capital Alternatives, LLC | 10% owner | 10,950,000 | 7.85% | Nov 24, 2025 |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 10% owner | – | – | Nov 24, 2025 |
| Frank M. Sands | 10% owner | 13,018,965 | 9.33% | Nov 24, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Dennis N. Berman Director | Jul 30, 2026 | Option exercise | +21,854 | $1.26 | $27.54K | 21,854 |
| Capital Healthcare Fund LP RA 10% owner | Jul 29, 2026 | Other | −18,030,000 | – | – | 6,970,000 |
| Vincent Aurentz Director | Feb 21, 2026 | Returned to company | −255,299 | – | – | 510,596 |
| Christopher Cabell President & Head of R&D | Feb 21, 2026 | Returned to company | −338,282 | – | – | 676,564 |
| Amit Munshi Director | Feb 21, 2026 | Returned to company | −19,089 | – | – | 38,176 |
| Frank M. Sands 10% owner | Nov 21, 2025 | Buy | +2,068,965 | $1.45 | $3.00M | 13,018,965 |
| Amit Munshi Director | Feb 21, 2025 | Award | +57,265 | – | – | 57,265 |
| Roberto Bellini Director | Oct 21, 2024 | Buy | +1,460,000 | $1.37 | $2.00M | 1,460,000 |
| Amit Munshi Director | Oct 21, 2024 | Buy | +365,000 | $1.37 | $500.05K | 365,000 |
| Arvind Kush Director | Oct 21, 2024 | Buy | +145,000 | $1.37 | $198.65K | 145,000 |
| Milton H. Werner President and CEO, Director, 10% owner | Aug 16, 2022 | Buy | +5,000 | $0.80 | $4.00K | 5,335,433 |
| Milton H. Werner President and CEO, Director, 10% owner | May 27, 2022 | Buy | +5,000 | $0.98 | $4.90K | 5,330,433 |
| Milton H. Werner President and CEO, Director, 10% owner | May 20, 2022 | Buy | +10,000 | $0.60 | $6.00K | 5,325,433 |
| Joseph Frattaroli Chief Financial Officer | May 19, 2022 | Buy | +3,948 | $0.64 | $2.53K | 48,091 |
| Milton H. Werner President and CEO, Director, 10% owner | Jan 3, 2022 | Option exercise | +21,853 | $2.02 | $44.14K | 5,315,433 |
| Milton H. Werner President and CEO, Director, 10% owner | Nov 17, 2021 | Buy | +1,100 | $1.97 | $2.17K | 23,589 |
| Milton H. Werner President and CEO, Director, 10% owner | Nov 17, 2021 | Buy | +17,569 | $1.98 | $34.79K | 23,589 |
| Milton H. Werner President and CEO, Director, 10% owner | Nov 17, 2021 | Buy | +1,334 | $1.94 | $2.59K | 23,589 |
| Milton H. Werner President and CEO, Director, 10% owner | Nov 17, 2021 | Buy | +400 | $1.93 | $772 | 23,589 |
| Milton H. Werner President and CEO, Director, 10% owner | Nov 17, 2021 | Buy | +3,186 | $1.96 | $6.24K | 23,589 |
| Milton H. Werner President and CEO, Director, 10% owner | Aug 17, 2021 | Option exercise | +21,853 | $2.02 | $44.14K | 5,293,580 |
| Milton H. Werner President and CEO, Director, 10% owner | May 14, 2021 | Tax withholding | −16,918 | $4.59 | $77.65K | 5,271,727 |
| Milton H. Werner President and CEO, Director, 10% owner | May 14, 2021 | Option exercise | +43,707 | $0.38 | $16.61K | 5,288,645 |
| Joseph Frattaroli Chief Financial Officer | Dec 28, 2020 | Conversion | +44,143 | $10.00 | $441.43K | 44,143 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.